Title for MeetingAbstracts
Alphabetical listing of titles
Steady State Nevirapine Pharmacokinetics during Second and Third Trimester Pregnancy and Postpartum: PACTG 1022.
Steady state pharmacokinetic (PK) of Lopinavir (LPV) in combination with Nevirapine (NVP) or Efavirenz (EFV).
Steady State Pharmacokinetics of Saquinavir Hard Gel/Fosamprenavir 1000/700 plus 100 mg and 200 mg of Ritonavir Twice Daily in HIV+ Patients.
Steady-state (SS) pharmacokinetics (PK) of delavirdine (DLV) in HIV+ patients: in vivo effect of DLV on the erythromycin breath test (ERMBT).
Steady-State Indinavir (Crixivan) Pharmacokinetics in Cerebrospinal Fluid (CSF) and Plasma in Patients Receiving Low-Dose Ritonavir (Norvir), as Determined by Ultra-Intensive CSF Sampling.
Steady-state kinetic characterization of a recombinant RNase H-deficient HIV-1 reverse transcriptase.
Steady-state Pharmaccokinetics of double boosting regimen of Lopinavir, plus Minidose Ritonavir, plus Saquinavir Soft-Gel in HIV-infected adults.
Steady-state pharmacokinetic (PK) interaction of modified-dose indinavir.
Steady-State Pharmacokinetic (PK) Interaction Study of Atazanavir (ATV) with Clarithromycin (CLR) in Healthy Subjects.
Steady-State Pharmacokinetic (PK) Interaction Study of Atazanavir (ATV) with Lamivudine (3-TC) and Zidovudine (ZDV) in Healthy Subjects.
Steady-State Pharmacokinetic (PK) Interaction Study of Atazanavir (ATV) with Ritonavir (RTV) in Healthy Subjects.
Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
Steady-State Pharmacokinetic Interaction Study between BMS-232632 and Ketoconazole in Healthy Subjects.
Steady-state pharmacokinetic interaction study between BMS-232632 and ritonavir in healthy subjects.
Steady-State Pharmacokinetic Interaction Study of Atazanavir (ATV) with Efavirenz (EFV) and Ritonavir (RTV) in Healthy Subjects.
Steady-state pharmacokinetic interactions between ritonavir (RTV), nelfinavir (NFV), and the nelfinavir active metabolite M8 (AG1402).
STEADY-STATE PHARMACOKINETICS (PK) AND SHORT-TERM VIROLOGIC RESPONSE OF TWO LOPINAVIR/RITONAVIR (LPV/r) HIGH-DOSE REGIMENS IN MULTIPLE ANTIRETROVIRAL (ARV)-EXPERIENCED SUBJECTS.
Steady-state pharmacokinetics (PK) of saquinavir (SQV) with and without two doses of itraconazole in HIV-1+ Thai patients:HIV NAT001.2 substudy.
Steady-state pharmacokinetics of a new triple combination tablet (TCT) containing abacavir (ABC), lamidudine (3TC) and zidovudine (ZDV) in subjects with HIV-1 infection.
Steady-state pharmacokinetics of lamivudine in HIV-infected subjects undergoing hemodialysis.
Steady-state pharmacokinetics of nelfinavir mesylate (NFV; Viracept in HIV-infected children.
Steady-State Phenytoin (PHT) Administration Does Not Alter Steady-State Clinafloxacin (CLX) Pharmacokinetics.
Steady-state plasma pharmacokinetics of amprenavir (APV) 450 mg bid and ritonavir (RTV) 200 mg bid with or without Efavirenz (EFV) in HIV-1 infected Individuals.
Steady-state protease diversity in untreated HIV-1-infected patients.
Steadys, roll-ons and hit and runs: using indigenous typology to measure number of sexual partners.
Steep declines in mortality and no AIDS deaths in HAART treated patients.
Stella: addressing sex workers' risk for HIV/AIDS in context.